| Literature DB >> 35617651 |
Andrew M Moon1, Joleen A Borgerding1, Ronald G Hauser1, Elliott Lowy1, Maggie Chartier1, Marissa M Maier1, Timothy Morgan1, Adam Ruege1, Jillian Weber1, Lauren A Beste1.
Abstract
We assessed hepatitis A (HepA) vaccine receipt among susceptible individuals in outbreak and matched nonoutbreak states. Difference-in-differences models and multivariable logistic regression were used to compare HepA vaccination rates in these states. In the postoutbreak year, there was a 112% increase in HepA vaccinations in outbreak states versus a 6% decrease in nonoutbreak states. Differences persisted in our multivariable model (adjusted odds ratio = 2.53; 95% confidence interval = 2.45, 2.61). HepA vaccination rates increased dramatically in outbreak states, but many individuals susceptible to hepatitis A virus remain unvaccinated. (Am J Public Health. 2022;112(7):990-994. https://doi.org/10.2105/AJPH.2022.306845).Entities:
Mesh:
Substances:
Year: 2022 PMID: 35617651 PMCID: PMC9222460 DOI: 10.2105/AJPH.2022.306845
Source DB: PubMed Journal: Am J Public Health ISSN: 0090-0036 Impact factor: 11.561